We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$9.71B
AUM Growth
-$405M
Cap. Flow
-$603M
Cap. Flow %
-6.21%
Top 10 Hldgs %
61.24%
Holding
100
New
9
Increased
6
Reduced
17
Closed
11

Top Buys

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$331M
2
VIPS icon
Vipshop
VIPS
+$213M
3
MNSO icon
MINISO
MNSO
+$128M
4
BABA icon
Alibaba
BABA
+$128M
5
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
+$42.6M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$432M
2
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$351M
3
ZM icon
Zoom
ZM
+$316M
4
GDS icon
GDS Holdings
GDS
+$214M
5
APLS
Apellis Pharmaceuticals
APLS
+$84M

Sector Composition

Rank Sector Weight
1 Healthcare 42.46%
2 Consumer Discretionary 24.31%
3 Technology 11.89%
4 Communication Services 10.14%
5 Financials 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOSS icon
26
Gossamer Bio
GOSS
$92.1M
$60.3M 0.62%
7,420,974
– –
TUYA
27
Tuya Inc
TUYA
$1.05B
$58.2M 0.6%
2,375,000
– –
BPMC
28
DELISTED
Blueprint Medicines
BPMC
$55.9M 0.58%
635,302
-123,389
-16% -$11.3M
AMG icon
29
Affiliated Managers Group
AMG
$9.62B
$51.7M 0.53%
335,073
– –
OTIS icon
30
Otis Worldwide
OTIS
$27.7B
$50.3M 0.52%
614,556
– –
TIL icon
31
Instil Bio
TIL
$49.2M
$46.1M 0.47%
119,273
– –
NIO icon
32
NIO
NIO
$12B
$45.7M 0.47%
859,200
+732,000
+575% +$29.3M
ALGS icon
33
Aligos Therapeutics
ALGS
$25.7M
$44.1M 0.45%
86,603
– –
TSM icon
34
TSMC
TSM
$1.96T
$43.3M 0.45%
360,495
– –
DIDI
35
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$42.6M 0.44%
+3,016,060
New +$42.6M
BZ icon
36
Kanzhun
BZ
$7.22B
$41.6M 0.43%
+1,050,000
New +$40.4M
AKRO
37
DELISTED
Akero Therapeutics
AKRO
$41.1M 0.42%
1,656,673
– –
KNSA icon
38
Kiniksa Pharmaceuticals
KNSA
$6.12B
$40.7M 0.42%
2,920,023
– –
XPEV icon
39
XPeng
XPEV
$12.5B
$39.8M 0.41%
896,500
+237,905
+36% +$8.11M
LYEL icon
40
Lyell Immunopharma
LYEL
$317M
$38.1M 0.39%
+117,448
New +$38.5M
GDS icon
41
GDS Holdings
GDS
$5.96B
$30.6M 0.32%
390,000
-2,753,623
-88% -$214M
HTHT icon
42
Huazhu Hotels Group
HTHT
$13.3B
$30.6M 0.31%
578,902
– –
MLCO icon
43
Melco Resorts & Entertainment
MLCO
$2.19B
$28.1M 0.29%
1,698,877
– –
ROOT icon
44
Root
ROOT
$927M
$28.1M 0.29%
144,444
– –
AAPL icon
45
Apple
AAPL
$5.01T
$27.4M 0.28%
200,000
– –
FMTX
46
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$27.4M 0.28%
1,100,000
– –
LEGN icon
47
Legend Biotech
LEGN
$3.64B
$26.7M 0.27%
650,000
– –
EM
48
DELISTED
Smart Share Global Ltd
EM
$24.8M 0.25%
+4,080,000
New +$28.9M
AXSM icon
49
Axsome Therapeutics
AXSM
$11.7B
$24.3M 0.25%
360,000
– –
ACMR icon
50
ACM Research
ACMR
$4.46B
$22.9M 0.24%
670,755
– –
1
2
3 4

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, HHLR Advisors held 100 positions worth $9.71B, down 4% from $10.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

HHLR Advisors withdrew a net $603M in Q2 2021, closing 11 positions and reducing 17 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $351M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, HHLR Advisors opened a new position in Airbnb worth $324M.

  • HHLR Advisors's largest Q2 2021 buy was Airbnb: 2,112,637 shares worth $324M.
  • HHLR Advisors added most to Vipshop in Q2 2021, an estimated $213M increase.
  • HHLR Advisors's biggest Q2 2021 reduction was Pinduoduo, cutting an estimated $432M.
  • HHLR Advisors fully exited China Biologic Products Holdings, Inc. in Q2 2021, selling an estimated $351M.
  • HHLR Advisors's ten largest holdings make up 61% of its $9.71B portfolio in Q2 2021.
  • HHLR Advisors opened 9 new positions and closed 11 in Q2 2021.
  • HHLR Advisors's portfolio value fell 4% quarter-over-quarter to $9.71B.

Based on HHLR Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.